FQ
CBIO

First Quadrant’s Crescent Biopharma CBIO Stock Holding History

First Quadrant’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-36
Closed -$11K – 551
2021
Q1 		$11K Sell
36
-19
-35% -$6.8K ﹤0.01% 559
2020
Q4 		$21K Buy
+55
New +$19.3K ﹤0.01% 516
2020
Q3 		– Sell
-264
Closed -$99K – 653
2020
Q2 		$99K Buy
+264
New +$74.8K 0.01% 549
2019
Q1 		– Sell
-13
Closed -$12K – 747
2018
Q4 		$12K Hold
13
– – ﹤0.01% 779
2018
Q3 		$18K Buy
+13
New +$19.7K ﹤0.01% 815

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return